Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study

Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study

Abstract Introduction Almost one-quarter of Asian patients with diabetes experience diabetic peripheral neuropathic pain (DPNP), which may be associated with moderate or severe levels of pain, insomnia, mood disorders, and worsened quality of life. Current treatments are generally ineffective and ma...

Full description

Bibliographic Details
Main Authors: Masayuki Baba, Masanori Kuroha, Shoichi Ohwada, Emiko Murayama, Norimitsu Matsui
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-02-01
Series:Pain and Therapy
Subjects:
Clinical trial
Diabetic peripheral neuropathy
Mirogabalin
Pain management
Phase 2
Pregabalin
Online Access:https://doi.org/10.1007/s40122-020-00156-6

Internet

https://doi.org/10.1007/s40122-020-00156-6

Similar Items